Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 17.2B | 15.1B | 14.5B | 16.2B |
Cost of revenue | 13.5B | 11.9B | 11.6B | 13.0B |
Gross profit | 3.7B | 3.2B | 3.0B | 3.2B |
Operating expense | ||||
Research & development | 384.6M | 357.3M | 357.6M | 394.8M |
Selling general and admin | 1.6B | 1.3B | 1.6B | 1.5B |
Other operating expenses | — | — | — | — |
Operating income | 1.8B | 1.5B | 1.1B | 1.3B |
Non operating interest income | ||||
Income | 104.6M | 89.0M | 205.9M | 169.7M |
Expense | 124.6M | 116.2M | 116.7M | 106.7M |
Other income expense | — | — | — | — |
Pretax income | 1.7B | 1.7B | 1.3B | 1.4B |
Tax provision | 404.2M | 316.0M | 203.9M | 225.7M |
Net income | 1.3B | 1.3B | 1.1B | 1.1B |
Basic EPS | 1.5 | 1.5 | — | 1.3 |
Diluted EPS | 1.5 | 1.5 | — | 1.3 |
Basic average shares | 790.0M | 792.6M | — | 790.0M |
Diluted average shares | 790.0M | 793.5M | — | 796.0M |
EBITDA | 2.2B | 2.2B | 1.8B | 1.9B |
Net income from continuing op. | 1.7B | 1.7B | 1.3B | 1.4B |
Minority interests | -110.3M | -115.3M | -71.6M | -89.3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |